Literature DB >> 6283173

Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII.

D H Spector, L Hock, J C Tamashiro.   

Abstract

We have used cloned EcoRI fragments of the human CMV (HCMV) genome, strain AD169, to prepare restriction endonuclease maps of the DNA. Individual 32P-labeled cloned fragments were hybridized to Southern blots of HCMV DNA cleaved to completion with the restriction endonucleases BglII and HindIII and cleaved partially with EcoRI. By determining which EcoRI fragments hybridized to the same band on a Southern blot, we were able to establish linkage groups. This information coupled with the data derived from digestion of the cloned fragments with the enzymes BglII and HindIII (Tamashiro et al., J. Virol. 42:547-557, 1982) provided the basis for the construction of detailed maps for the enzymes EcoRI, BglII, and HindIII. We also identified the EcoRI fragments derived from the termini of this genome and mapped them with respect to the BglII and HindIII terminal fragments. From our mapping data, we conclude that the genome of HCMV is approximately 240 kilobases in length and is divided into long (198 kilobases) and short (42 kilobases) regions. Both regions consist of a unique sequence bounded by inverted repeats (11 to 12 kilobases for the long region and 2 to 3 kilobases for the short region). Furthermore, the long and short regions can invert relative to each other.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6283173      PMCID: PMC256882     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Size of infectious DNA from human and murine cytomegaloviruses.

Authors:  A D Lakeman; J E Osborn
Journal:  J Virol       Date:  1979-04       Impact factor: 5.103

2.  Size and complexity of human cytomegalovirus DNA.

Authors:  J M DeMarchi; M L Blankenship; G D Brown; A S Kaplan
Journal:  Virology       Date:  1978-09       Impact factor: 3.616

3.  Structure of the joint region and the termini of the DNA of herpes simplex virus type 1.

Authors:  M J Wagner; W C Summers
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

4.  Analysis of cytomegalovirus genomes with restriction endonucleases Hin D III and EcoR-1.

Authors:  B A Kilpatrick; E S Huang; J S Pagano
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

5.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

6.  Analysis of herpesvirus DNA substructure by means of restriction endonucleases.

Authors:  J B Clements; R Cortini; N M Wilkie
Journal:  J Gen Virol       Date:  1976-02       Impact factor: 3.891

7.  Human cytomegalovirus DNA. I. Molecular weight and infectivity.

Authors:  J L Geelen; C Walig; P Wertheim; J van der Noordaa
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

8.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

9.  Anatomy of herpes simplex virus DNA: evidence for four populations of molecules that differ in the relative orientations of their long and short components.

Authors:  G S Hayward; R J Jacob; S C Wadsworth; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

10.  Human cytomegalovirus genome: partial denaturation map and organization of genome sequences.

Authors:  B A Kilpatrick; E S Huang
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

View more
  42 in total

1.  Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.

Authors:  W L William Chang; Peter A Barry
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer.

Authors:  Montse Gustems; Eva Borst; Chris A Benedict; Carmen Pérez; Martin Messerle; Peter Ghazal; Ana Angulo
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Multicomponent origin of cytomegalovirus lytic-phase DNA replication.

Authors:  D G Anders; S M Punturieri
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

4.  The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43.

Authors:  D J Dargan; F E Jamieson; J MacLean; A Dolan; C Addison; D J McGeoch
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome.

Authors:  E S Mocarski; M N Prichard; C S Tan; J M Brown
Journal:  Virology       Date:  1997-12-08       Impact factor: 3.616

6.  Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit.

Authors:  D A Wright; D H Spector
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

7.  Primate cytomegalovirus assembly protein: genome location and nucleotide sequence.

Authors:  L Robson; W Gibson
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

Review 8.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

9.  A cytomegalovirus protein with properties of herpes simplex virus ICP8: partial purification of the polypeptide and map position of the gene.

Authors:  G W Kemble; A L McCormick; L Pereira; E S Mocarski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

10.  Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD169.

Authors:  D A Wright; S I Staprans; D H Spector
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.